Guided Therapeutics Stock Today
| GTHP Stock | USD 0.16 0.03 15.79% |
Performance6 of 100
| Odds Of DistressOver 80
|
Guided Therapeutics is selling at 0.16 as of the 27th of November 2024; that is 15.79 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.16. Guided Therapeutics has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Guided Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia. Guided Therapeutics operates under Medical Devices classification in the United States and is traded on OTC Exchange. The company has 48.58 M outstanding shares. More on Guided Therapeutics
Moving against Guided OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Guided OTC Stock Highlights
| CEO | Gene Cartwright |
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Guided Therapeutics [GTHP] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Guided Therapeutics's market, we take the total number of its shares issued and multiply it by Guided Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Guided Therapeutics conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 48.58 M outstanding shares.
Guided Therapeutics currently holds about 446 K in cash with (1.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Guided Therapeutics Probability Of Bankruptcy
Ownership AllocationGuided Therapeutics has a total of 48.58 Million outstanding shares. Guided Therapeutics secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Guided Ownership Details
Guided Therapeutics Risk Profiles
| Mean Deviation | 11.05 | |||
| Semi Deviation | 12.58 | |||
| Standard Deviation | 15.49 | |||
| Variance | 239.91 |
Guided Stock Against Markets
Picking the right benchmark for Guided Therapeutics otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Guided Therapeutics otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Guided Therapeutics is critical whether you are bullish or bearish towards Guided Therapeutics at a given time. Please also check how Guided Therapeutics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Guided Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Additional Tools for Guided OTC Stock Analysis
When running Guided Therapeutics' price analysis, check to measure Guided Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guided Therapeutics is operating at the current time. Most of Guided Therapeutics' value examination focuses on studying past and present price action to predict the probability of Guided Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guided Therapeutics' price. Additionally, you may evaluate how the addition of Guided Therapeutics to your portfolios can decrease your overall portfolio volatility.